Antiphospholipid antibodies and fetal death

Obstetrics and Gynecology

Volumn 87, Issue 4, 1996, Pages 489-493

  Oshiro, Bryan T ^a,b   Silver, Robert M ^a   Scott, James R ^a   Yu, Huixia ^a   Branch, D Ware ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b McKay Dee Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; FEMALE; FETUS DEATH; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 0029988795     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00498-X     Document Type: Article

References (37)

1. Alarcon-Segovia D, Deleze M, Oria C, Sanchez-Guerrero J, Gomez-Pancheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective study of 500 consecutive cases. Medicine 1989;68:353-63.
2. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of the cardiolipin antibody tests. Arch Intern Med 1986;146:2153-6.
3. Asherson RA, Cervera R. The antiphospholipid syndrome: A syndrome in evolution. Ann Rheum Dis 1992;51:147-50.
4. Rote NS, Walter A, Lyden TW. Antiphospholipid antibodies -Lobsters or red herrings? Am J Reprod Immunol 1992;28:31-7.
5. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989;20:52-67.
6. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989;48: 362-7.
7. Lockshin MD. Antiphospholipid antibody syndrome. JAMA 1992; 268:1451-3.
8. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989; 68:366-74.
9. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med 1994;96:3-9.
10. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614-20.
11. Silver RM, Draper ML, Scott JM, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet Gynecol 1994;83:372-7.
12. Harris EN. The Second International Anti-cardiolipin Standardization Workshop: The Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-84.
13. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985;313:1322-6.
14. Martin BA, Branch DW, Rodgers GM. The preparation of a partial thromboplastin reagent from bovine brain. Blood Coagul Fibrinolysis 1992;3:287-94.
15. Moore KL. The developing human. 3rd ed. Philadelphia: WB Saunders, 1982.
16. Warbuton D, Stein Z, Kline J, Susser M. Chromosome abnormalities in spontaneous abortion: Data from the New York City study. In: Porter IH, Hook EB, eds. Human embryonic and fetal death. New York: Academic Press, 1980:261.
17. Boue J, Boue A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology 1975;12:11-7.
18. Warburton D. Chromosomal causes of fetal death. Clin Obstet Gynecol 1987;30:268-77.
19. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril 1982;38:447-53.
20. Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A. Fetal loss after implantation; a prospective study. Lancet 1980;ii:554-7.
21. Simpson JL, Mills JL, Holmes LB, Ober CL, Aarons J, Jovanovic L, et al. Low fetal loss rate after ultrasound-proved viability in early pregnancy. JAMA 1987;258:2555-7.
22. Goldstein SR. Embryonic death in early pregnancy: A new look at the first trimester. Obstet Gynecol 1994;84:294-7.
23. De Wolf F, Carreras LO, Moerman P, Vermyelen J, van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829-34.
24. Harris EN. Syndrome of the black swan. Br J Rheumatol 1986;26: 324-6.
25. Taylor M, Cauchi MN, Buchanan RRC. The lupus anticoagulant, anticardiolipin antibodies, and recurrent miscarriage. Am J Reprod Immunol 1990;23:33-6.
26. Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum 1987;30:601-6.
27. Eroglu GE, Scopelitis E. Antinuclear and antiphospholipid antibodies in healthy women with recurrent spontaneous abortion. Am J Reprod Immunol 1994;31:1-6.
28. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Corgelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991;77:854-8.
29. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991;34:1231-5.
30. Barbui T, Cortelazzo S, Galli M, Parazzini F, Radici E, Rossi E, et al. Antiphospholipid antibodies in early repeated abortions: A case-controlled study. Fertil Steril 1988;50:589-92.
31. Creagh MD, Malia RG, Cooper SM, Smith AR, Duncan SLB, Greaves M. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. J Clin Pathol 1991;44:45-7.
32. Out HJ, Bruinse HW, Derksen RHWM. Antiphospholipid antibodies and pregnancy loss. Hum Reprod 1991;6:889-97.
33. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
34. Silver RK, MacGregor SN, Sholl JS, Hobart JH, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-7.
35. Whittaker PG, Taylor A, Lind T. Unsuspected pregnancy loss in healthy women. Lancet 1983;i:1126-7.
36. Reece EA, Gabrielli S, Cullen MT, Zheng X-Z, Hobbins JC, Harris EN. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990;163:162-9.
37. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.